Cullinan Oncology Inc. (CGEM) Social Stream
CULLINAN ONCOLOGY INC (CGEM) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering CULLINAN ONCOLOGY INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-16 | 4 | $55 | $43 | $51.75 | $10.41 | 397.12% |
| 2022-01-31 | 2 | $55 | $27 | $45.333 | $10.41 | 335.48% |
| 2022-03-17 | 3 | $55 | $27 | $39.333 | $10.41 | 277.84% |
| 2022-05-12 | 3 | $53 | $27 | $38.666 | $10.41 | 271.43% |
| 2022-05-16 | 3 | $53 | $25 | $35 | $10.41 | 236.22% |
| 2022-11-15 | 3 | $50 | $25 | $34 | $10.41 | 226.61% |
| 2022-11-21 | 4 | $50 | $20 | $30.5 | $10.41 | 192.99% |
| 2023-02-14 | 4 | $50 | $19 | $28.5 | $10.41 | 173.78% |
| 2023-05-12 | 4 | $50 | $19 | $28.75 | $10.41 | 176.18% |
| 2023-06-05 | 4 | $49 | $19 | $29 | $10.41 | 178.58% |
| 2023-08-10 | 5 | $49 | $19 | $29 | $10.41 | 178.58% |
| 2023-11-09 | 5 | $34 | $19 | $25.25 | $10.41 | 142.56% |
The Trend in the Analyst Price Target
Over the past 29 months, CGEM's average price target has gone down $26.5.
Over the past 40 weeks, CGEM's average upside potential has been 165.58%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-14 | 4 | 50 | 19 | 28.75 | 11.38 | 152.64% |
| 2023-06-05 | 4 | 49 | 19 | 28.50 | 11.65 | 144.64% |
| 2023-07-07 | 5 | 49 | 19 | 29.00 | 10.28 | 182.1% |
| 2023-11-08 | 5 | 34 | 19 | 25.25 | 9.94 | 154.02% |
| 2023-11-09 | 5 | 34 | 19 | 27.00 | 9.59 | 181.54% |
CGEM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 13 months, CGEM's average broker recommendation rating improved by 0.33.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CGEM as an investment opportunity.
- CULLINAN ONCOLOGY INC's upside potential (average analyst target price relative to current price) is greater than 1498.03% of all US stocks.
- CULLINAN ONCOLOGY INC's number of analysts covering the stock is greater than 206.99% of all US stocks.
- CULLINAN ONCOLOGY INC's variance in analysts' estimates is lower than -1196.78% of all US stocks.
- CGEM has a higher average analyst price target than 1325.68% of stocks in the small market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CULLINAN ONCOLOGY INC are SABS, VOR, and FNCH.
View All Top Stocks by Price Target
Is CGEM a Buy, Hold or Sell? See the POWR Ratings now!